Stage IV Colorectal Cancer Recruiting Phase 2 Trials for Metformin (DB00331)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03800602Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerTreatment